Skip Navigation
Skip to contents

PHRP : Osong Public Health and Research Perspectives



Page Path
HOME > Osong Public Health Res Perspect > Volume 2(Suppl 1); 2011 > Article
Articles Novel Trend in Vaccine Research
Daniel Douek
Osong Public Health and Research Perspectives 2011;2(Suppl 1):S8-S8.
Published online: November 30, 2011
  • 13 Download

Senior Investigator and Chief, NIAID, NIH, USA

Copyright ©2012, Korea Centers for Disease Control and Prevention

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

dd class="first" id="idm140291150023008">Even before the partial success of a preventive HIV vaccine in a recent Phase III clinical trial, there has been an active discovery effort to determine one or more immune correlates of protection in HIV infection. This effort has been hampered by the lack of natural protective immunity against HIV. I will discuss lessons learned from the STEP and RV144 trials and how the Vaccine Research Center is proceeding with the HVTN505 study. I will discuss efforts to elicit broadly neutralizing antibodies and the importance of establishing correlates of immunity from studies in humans.

Figure & Data



    Citations to this article as recorded by  

      PHRP : Osong Public Health and Research Perspectives